Enterprise Value

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

Burford Capital's leadership invests millions from their own pay, claiming shares are deeply discounted. But will the market agree with their bold move?

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

100 Teamsters at Atlanta's airport secured major wage hikes and benefits, a victory that could ripple through the entire rental car industry.

For the third straight year, Sunbit is on the Forbes Fintech 50. We explore its unique fee-free model, merchant-first strategy, and impact on real-world finance.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

As AI pushes data centers to their limits, the optical industry gathers at OFC 2026 to unveil the power-efficient, high-speed networks of the future.

Clinical-stage biotech BioVie announces its novel anti-inflammatory drug, bezisterim, will be featured at a key psychiatric conference for its potential.

Lincoln International data reveals slowing growth and rising debt distress in private companies, a stark contrast to the heated M&A market for top assets.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

The asset manager starts 2026 with a bang, fueled by massive European inflows, a strategic shift to higher-fee products, and resilient digital asset growth.

NervGen Pharma to unveil data showing its drug NVG-291 provides lasting functional gains for chronic spinal cord injury, a major step forward.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.